365 related articles for article (PubMed ID: 37457696)
21. Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report.
Jia Y; Liu L; Deng B; Huang Y; Zhao J; Bai G
Diagn Pathol; 2022 Jul; 17(1):57. PubMed ID: 35787279
[TBL] [Abstract][Full Text] [Related]
22. Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
Gao L; Wang L; Woo E; He X; Yang G; Bowlus C; Leung PSC; Gershwin ME
Clin Rev Allergy Immunol; 2020 Oct; 59(2):175-194. PubMed ID: 31713023
[TBL] [Abstract][Full Text] [Related]
23. Primary Biliary Cholangitis in Males: Pathogenesis, Clinical Presentation, and Prognosis.
Shaker M; Mansour N; John BV
Clin Liver Dis; 2022 Nov; 26(4):643-655. PubMed ID: 36270721
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?
Mayo MJ
Hepatology; 2022 Aug; 76(2):518-531. PubMed ID: 35152430
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and Treatment of Primary Biliary Cholangitis].
Kim KA
Korean J Gastroenterol; 2023 Feb; 81(2):86-90. PubMed ID: 36824036
[TBL] [Abstract][Full Text] [Related]
26. Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis.
Sasaki M; Kakuda Y; Miyakoshi M; Sato Y; Nakanuma Y
J Clin Pathol; 2014 Jun; 67(6):470-6. PubMed ID: 24407434
[TBL] [Abstract][Full Text] [Related]
27. Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis.
Harada K; Isse K; Tsuneyama K; Ohta H; Nakanuma Y
Liver Int; 2003 Apr; 23(2):94-100. PubMed ID: 12654131
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
Nakanishi Y; Saxena R
Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
[TBL] [Abstract][Full Text] [Related]
29. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis.
Haruta I; Hashimoto E; Kato Y; Kikuchi K; Kato H; Yagi J; Uchiyama T; Kobayash M; Shiratori K
Autoimmunity; 2006 Mar; 39(2):129-35. PubMed ID: 16698669
[TBL] [Abstract][Full Text] [Related]
30. Primary biliary cirrhosis.
Hohenester S; Oude-Elferink RP; Beuers U
Semin Immunopathol; 2009 Sep; 31(3):283-307. PubMed ID: 19603170
[TBL] [Abstract][Full Text] [Related]
31. Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts.
Zen Y; Harada K; Sasaki M; Tsuneyama K; Matsui K; Haratake J; Sakisaka S; Maeyama S; Yamamoto K; Nakano M; Shimamatsu K; Kage M; Kurose N; Uchiyama A; Kaizaki Y; Toda G; Nakanuma Y
J Gastroenterol; 2005 Feb; 40(2):164-70. PubMed ID: 15770400
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature.
Bowlus CL; Yang GX; Liu CH; Johnson CR; Dhaliwal SS; Frank D; Levy C; Peters MG; Vierling JM; Gershwin ME
J Autoimmun; 2019 Jul; 101():26-34. PubMed ID: 31027870
[TBL] [Abstract][Full Text] [Related]
33. B7-2 positive cells around interlobular bile ducts in primary biliary cirrhosis and chronic hepatitis C.
Kaji K; Tsuneyama K; Nakanuma Y; Harada K; Sasaki M; Kaneko S; Kobayashi K
J Gastroenterol Hepatol; 1997 Jul; 12(7):507-12. PubMed ID: 9257241
[TBL] [Abstract][Full Text] [Related]
34. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.
Kennedy L; Carpino G; Owen T; Ceci L; Kundu D; Meadows V; Kyritsi K; Franchitto A; Onori P; Isidan A; Zhang W; Ekser B; Alvaro D; Gaudio E; Gershwin ME; Francis H; Glaser S; Alpini G
J Hepatol; 2023 Jan; 78(1):99-113. PubMed ID: 35987275
[TBL] [Abstract][Full Text] [Related]
35. The pathogenesis, models and therapeutic advances of primary biliary cholangitis.
Li H; Guan Y; Han C; Zhang Y; Liu Q; Wei W; Ma Y
Biomed Pharmacother; 2021 Aug; 140():111754. PubMed ID: 34044277
[TBL] [Abstract][Full Text] [Related]
36. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
Ludwig J
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
[TBL] [Abstract][Full Text] [Related]
37. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
38. Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis.
Bauer A; Habior A
Front Immunol; 2022; 13():885229. PubMed ID: 35529854
[TBL] [Abstract][Full Text] [Related]
39. [Primary biliary cholangitis and bile acid metabolism].
Wang L; Han YC; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):874-877. PubMed ID: 29325285
[TBL] [Abstract][Full Text] [Related]
40. Atypical biliary cirrhosis--or sclerosing cholangitis.
Galambos JT; Brooks WS
J Clin Gastroenterol; 1980 Mar; 2(1):43-52. PubMed ID: 7347356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
